ThursdayApr 29, 2021 9:34 am

Burgeoning Plant-Based Health Products Market Holds Promise for Healthy Extracts Inc. (HYEX)

Healthy Extracts Inc. engages in proprietary R&D, sales and distribution of health products through its BergaMet North America and Ultimate Brain Nutrients (“UBN”) subsidiaries The global brain health supplements, UBN’s domain, is projected to grow at a CAGR of 8% from 2021 to 2028 The global heart health supplements market, BergaMet’s segment, is expected to witness a CAGR of 4.5% from 2020 to 2030 Overall, the global botanical and plant-derived drug market will potentially expand at a CAGR of 6.1% from 2017 to 2022 According to projections by various research firms, the global health products market is expected to continue…

Continue Reading

WednesdayApr 28, 2021 1:44 pm

Researchers Identify Human Genes That Fight SARS-CoV-2 Infection

Researchers have determined which set of human genes help fight the infection that is known to cause COVID-19, the SARS-CoV-2. This information could be beneficial in helping researchers understand the factors that influence the ailment’s severity, in addition to assisting in the formulation of therapies for the said disease. The research was reported in the “Molecular Cell” journal. The genes, which were identified by researchers from the Sanford Burnham Prebys Medical Discovery Institute are associated with the cells that fight viruses in the body, known as interferons. The lead author of the study, Prof. Sumit K. Chanda, stated that the…

Continue Reading

WednesdayApr 28, 2021 9:51 am

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Technology Development is at the Forefront of Bladder Cancer Visualization Innovation

The i/Blue Imaging System’s(TM) development is the first to harness the power of white light and blue light visualization techniques with the added capability of displaying multiple images simultaneously  which will help surgeons perform more accurate tumor resections Imagin Medical’s innovative system is currently in the manufacturing phase with Lighthouse Imaging with product completion slated for 2022 With its patented technology, the company is positioned to stake a claim on a $400 million segment of the $46 billion global endoscopy market Advancements in the way that cancer is diagnosed and treated continue to be made. On the forefront of new…

Continue Reading

TuesdayApr 27, 2021 3:06 pm

Stanford Team Finds AI to Safely Include Study Subjects Who Could Have Been Ruled Out Previously

A group of scientists from Stanford University in collaboration with Genentech, a biotechnology corporation, has created a system based on AI that can be used to safely add participants to clinical trials that they may have previously been barred from. The group’s findings were reported in the “Nature” journal, with Columbia University’s James Rogers and Chunhua Weng publishing a “News & Views” piece on the group’s research in the same journal. Many countries have put in place measures to ensure that all drugs undergo clinical trials before being approved for use by patients in order to demonstrate that, in addition…

Continue Reading

TuesdayApr 27, 2021 10:27 am

Brain Scientific Inc. (BRSF) Receives FDA Clearance for Next-Gen NeuroCap

BRSF announced it has FDA clearance for next-gen NeuroCap The newest version of the NeuroCap has added velcro strips, expanded size range to include pediatrics New device can stay on the patient’s head for up to four hours Brain Scientific (OTCQB: BRSF), a commercial-stage healthcare company, announced it has received clearance from the FDA for its next-generation NeuroCap(TM) (https://ibn.fm/RYmMH). This device is an advanced electroencephalogram (“EEG”) electrode array used in routine clinical and research settings. Like the previous version, the newest version of the NeuroCap will help improve patient access to neurological care through its simplicity, cost efficiency and one-time…

Continue Reading

MondayApr 26, 2021 11:33 am

Korean Researchers Develop Tech That Predicts Kidney Cancer Recurrence

A team of researchers has designed AI software that can forecast the recurrence of kidney cancer. The researchers, who are all from St. Mary’s Seoul Hospital, were led by Department of Urology Prof. Hong Seung-hoo. The research findings were reported in the “JMIR Medical Informatics” journal. The proposed algorithm can be used to forecast the probability of kidney recurrence five to 10 years after surgeries have been performed. It can predict this through the use of AI machine learning. In a press release, the group of researchers stated that they expect their software will be used as the foundation for…

Continue Reading

FridayApr 23, 2021 10:34 am

Brain Scientific Inc. (BRSF) Joins Forces with JelikaLite to Reduce Symptoms of Autism

BRSF and JelikaLite have joined forces in a clinical trial for reducing autism symptoms in children JelikaLite uses PRM therapy to reduce autism symptoms BRSF sees this as an important step forward in wider adoption of affordable, accessible EEG systems The neurology-focused medical device and software company Brain Scientific (OTCQB: BRSF) announced on March 16, 2021, it is collaborating with JelikaLite in a clinical trial. The clinical trial, which began in March 2021, is designed to potentially uncover new treatment options to reduce autism symptoms in children. The trial has 30 participants from two New York City locations. JelikaLite was…

Continue Reading

ThursdayApr 22, 2021 2:44 pm

Researchers Find Antioxidants That Can Help Prevent Cancerous HPV Infection in Women

A study conducted by a group of researchers from the Louisiana State University School of Public Health and Medicine, led by professor of biostatistics Hui-Yi Lin, has discovered that sufficient levels of five antioxidants may decrease infection with the human papilloma virus (“HPV”) strains that are linked to the development of cervical cancer. Their research was reported in the “Journal of Infectious Diseases.” While prior studies had proposed that the onset of HPV associated with cancer development could be triggered by oxidative stress, the link between the two had not been made clear. This research assessed the link between vaginal…

Continue Reading

WednesdayApr 21, 2021 2:41 pm

Researchers Find Possible Explanation Why Some Cancer Drugs Fail

A study done by researchers from the McGovern Medical School and the UTHealth School of Biomedical Informatics has found a likely reason why some cancer treatments that eliminate cancerous cells in mouse research models aren’t as effective during human trials. The study was reported in the Nature Communications journal. For the study, the researchers reported the broad existence of mouse virus cells seen in xenografts that were derived from patients. These patient-derived xenograft (“PDX”) models were created by implanting tumor tissues from humans in mice that are immune deficient. These mice are often used while developing and testing cancer treatments.…

Continue Reading

WednesdayApr 21, 2021 10:22 am

United Medical Equipment Business Solutions Network Inc. Continues Commitment to Public Health

Company remains committed to helping maintain safety and health during global pandemic Rapid testing identifies virus in the person, provides another layer of protection to the community UME kits help identify the virus quickly allowing companies and individuals to act quickly to isolate infected individuals United Medical Equipment Business Solutions Network distributes rapid antigen tests and comprehensive telehealth solutions that allow providers to work more proficiently, health-care systems to work smarter and patients to live healthier lives. Through the provision of COVID-19 rapid kit testing, UME is helping to maintain safety and health during a global pandemic. Rapid antigen testing…

Continue Reading

Official NewsWire Relationships

BIO Informa DGE Dynamic Global Events DTC Healthcare Conference Kiasco Reasearch Nexus Conferences Octane

BioMedWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000